Dual Myxovirus Screen Identifies a Small-Molecule Agonist of the Host Antiviral Response

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Virology

• Publication date

  2013-08-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/JVI.01425-13PMID 23926334PMCID PMC3807298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Online

  2014cited by this paper
• Structural basis for viral 5′-PPP-RNA recognition by human IFIT proteins

  2013cited by this paper
• Human viral diseases: what is next for antiviral drug discovery?

  2012cited by this paper
• Independent Structural Domains in Paramyxovirus Polymerase Protein*

  2012cited by this paper
• A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.

  2012cited by this paper
• Identification of Small Molecules with Type I Interferon Inducing Properties by High-Throughput Screening

  2012cited by this paper
• HTS Assay Validation

  2012cited by this paper
• Isoflavone Agonists of IRF-3 Dependent Signaling Have Antiviral Activity against RNA Viruses

  2012cited by this paper
• A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection.

  2012cited by this paper
• High Throughput Screening for Small Molecule Enhancers of the Interferon Signaling Pathway to Drive Next-Generation Antiviral Drug Discovery

  2012cited by this paper
• Four lessons from global health drug discovery: medicine for an ailing industry?

  2012cited by this paper
• Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis

  2011cited by this paper
• Monitoring Viral‐Mediated Membrane Fusion Using Fluorescent Reporter Methods

  2011cited by this paper
• Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease

  2011cited by this paper
• Potent Host-Directed Small-Molecule Inhibitors of Myxovirus RNA-Dependent RNA-Polymerases

  2011cited by this paper
• Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics

  2011cited by this paper
• Induction and evasion of type I interferon responses by influenza viruses.

  2011cited by this paper
• Mumps is back: why is mumps eradication not working?

  2011cited by this paper
• IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA

  2011cited by this paper
• Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication

  2010cited by this paper
• Human Host Factors Required for Influenza Virus Replication

  2010cited by this paper
• A broad-spectrum antiviral targeting entry of enveloped viruses

  2010cited by this paper
• web cellHTS2: A web-application for the analysis of high-throughput screening data

  2010cited by this paper
• Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells

  2010cited by this paper
• New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

  2010cited by this paper
• Factors Affecting Reproducibility between Genome-Scale siRNA-Based Screens

  2010cited by this paper
• Paramyxovirus Disruption of Interferon Signal Transduction: STATus Report

  2009cited by this paper
• Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy.

  2009cited by this paper
• Probing the Spatial Organization of Measles Virus Fusion Complexes

  2009cited by this paper
• Antiviral Strategies

  2009cited by this paper
• Target Analysis of the Experimental Measles Therapeutic AS-136A

  2009influential reference
• The Regulation of Type I Interferon Production by Paramyxoviruses

  2009cited by this paper
• Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding

  2009cited by this paper
• A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection.

  2009cited by this paper
• Interferon-inducible antiviral effectors

  2008cited by this paper
• Host-Directed Drug Targeting of Factors Hijacked by Pathogens

  2008cited by this paper
• Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.

  2007cited by this paper
• Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes.

  2007cited by this paper
• Nonnucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity

  2007cited by this paper
• Systems biology and the host response to viral infection

  2007cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• Measles Virus N Protein Inhibits Host Translation by Binding to eIF3-p40

  2007cited by this paper
• Interferons at age 50: past, current and future impact on biomedicine

  2007cited by this paper
• Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease.

  2006cited by this paper
• Analysis of cell-based RNAi screens

  2006cited by this paper
• Two Approaches to Drug Discovery in SOD1-Mediated ALS

  2006cited by this paper
• Antiviral agents active against influenza A viruses

  2006cited by this paper
• First demonstration of the effectiveness of inhibitors of cellular protein kinases in antiviral therapy

  2006cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

  2004cited by this paper
• A target site for template-based design of measles virus entry inhibitors.

  2004cited by this paper
• Influenza-associated hospitalizations in the United States.

  2004cited by this paper
• Assay Guidance Manual

  2004cited by this paper
• HTS Assay Validation -- Assay Guidance Manual

  2004cited by this paper
• Structure-based Inhibitor Discovery against Adenylyl Cyclase Toxins from Pathogenic Bacteria That Cause Anthrax and Whooping Cough*

  2003cited by this paper
• A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

  2002cited by this paper
• Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus.

  2001cited by this paper
• Measles Viruses on Throat Swabs from Measles Patients Use Signaling Lymphocytic Activation Molecule (CDw150) but Not CD46 as a Cellular Receptor

  2001cited by this paper
• p38 Mitogen-Activated Protein Kinase and c-Jun-NH2-Terminal Kinase Regulate RANTES Production by Influenza Virus-Infected Human Bronchial Epithelial Cells

  2001cited by this paper
• Plasmid-Driven Formation of Influenza Virus-Like Particles

  2000cited by this paper
• p38 Mitogen-Activated Protein Kinase and c-Jun-NH2-Terminal Kinase Regulate RANTES Production by Influenza Virus-Infected Human Bronchial Epithelial Cells1

  2000cited by this paper
• Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA: BRSV NS2 Is Not Essential for Virus Replication in Tissue Culture, and the Human RSV Leader Region Acts as a Functional BRSV Genome Promoter

  1999cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase

  1998cited by this paper
• Respiratory Syncytial Virus Immune Globulin

  1997cited by this paper
• Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

  1997cited by this paper
• Respiratory Syncytial Virus Immune Globulin

  1997cited by this paper
• Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.

  1997cited by this paper
• Croup

  1996cited by this paper
• A broad spectrum.

  1996cited by this paper
• Non‐replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase

  1995cited by this paper
• Rescue of measles viruses from cloned DNA.

  1995cited by this paper
• Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children

  1994cited by this paper
• Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.

  1994cited by this paper
• Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.

  1993cited by this paper
• Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

  1993cited by this paper
• Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children.

  1990cited by this paper
• Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion

  1986cited by this paper
• Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.

  1984cited by this paper
• The measles virus

  1980cited by this paper
• Intracellular synthesis of measles virus-specified polypeptides

  1978cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper
• World health statistics.

  1949cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir : descriptive study

  year unknowncited by this paper

• miR-29a is a negative regulator of influenza virus infection through targeting frizzled 5 receptor

  2021cites this paper
• miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor

  2020cites this paper
• Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity

  2020cites this paper
• Biological evaluation of an L-dideoxy bicyclic nucleoside analogue active against measles virus

  2019cites this paper
• Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex

  2018influential citation
• Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds

  2018cites this paper
• Novel role of the central unstructured Paramyxovirus nucleopcapsid protein tail domain

  2018cites this paper
• Identification of a small molecule that primes the type I interferon response to cytosolic DNA

  2017cites this paper
• 4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency.

  2017cites this paper
• Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening

  2016cites this paper
• Fluorescent and Bioluminescent Reporter Myxoviruses

  2016cites this paper
• Étude de molécules antivirales originales ciblant les fonctions cellulaires et la réponse immunitaire innée

  2016cites this paper
• Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.

  2015cites this paper
• Mitigating risk in academic preclinical drug discovery

  2015cites this paper
• [Stimulating Type I interferon response with small molecules: revival of an old idea].

  2015cites this paper
• Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening.

  2014cites this paper
• The RNA-dependent-RNA polymerase, an emerging antiviral drug target for the Hendra virus.

  2014cites this paper
• Development of a new class of antivirals active against pox and measles viruses

  2014cites this paper
• Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors

  2014cites this paper
• Efficient replication of a paramyxovirus independent of full zippering of the fusion protein six-helix bundle domain

  2014cites this paper
• Protein-protein and protein-small-molecule inhibitor interactions in the measles virus replication complex

  2013cites this paper